Company intelligence / Profile preview

Sterifre Medical

Kirkland, Washington, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

The AURA system received EPA registration in November 2021 and is designed for point-of-care disinfection of medical devices without harsh chemicals or heat. The device uses hydrogen peroxide and activated oxygen to disinfect equipment including stethoscopes, tablets, phones, and sensors.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Nottingham Spirk (design and development)Simplexity Product Development (manufacturing preparation)Minnetronix Medical (contract manufacturer)

Beyond the preview

Go deeper on Sterifre Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterifre Medical.

Explore the full profile